Senores Pharmaceuticals saw a strong market reception as its shares debuted with a premium of over 50 per cent on both the ...

According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ...

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.38 ...

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) Senores Pharmaceuticals IPO closes ...

Senores Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet USP, 50 mg/25 mg and ...

Technichem Organics IPO Share Listing: Issue ton open for subscription tomorrow (Image: Getty Images) Senores Pharmaceuticals, an emerging player in the pharma industry, has kicked off its IPO ...

The Ahmedabad-based Senores Pharmaceuticals, which launched its ₹582.11 crore IPO on Friday, at a price band of ₹372-391, saw a strong response on Day 1 with a subscription of 1.78 times.

Senores Pharma’s IPO is a book-built issue aggregating Rs 582.11 crore. It consists of a fresh issue of 1.27 crore equity shares and an offer for sale by promoters and other shareholders, who are ...

Senores Pharmaceuticals has filed red herring prospectus with the Registrar of Companies as it plans to launch IPO for public subscription on December 20. The company will disclose price band ...

Senores Pharmaceuticals Share Price Live Updates: Senores Pharmaceuticals shares made their Dalal Street debut today after high demand for its initial public offering (IPO). Senores ...